Preliminary findings on biomarker levels from extracerebral sources in patients undergoing trauma surgery: Potential implications for TBI outcome studies

BACKGROUND

Despite several experimental studies on the role of S100B and NSE in fractures, no studies on the influence of surgery on the biomarker serum levels have been performed yet.

METHODS

The serum levels of S100B and NSE were analysed in patients with fractures that were located in the spine (group 1, n = 35) or in the lower extremity (group 2, n = 32) pre- and post-operatively.

RESULTS

The mean S100B serum level showed a significant increase (p = 0.04) post-surgery in the patients of group 1. In patients undergoing acute surgery (< 24 hours) the mean S100B serum level was 0.23 ± 0.22 μg L(-1) pre-operatively and 1.24 ± 1.38 μg L(-1) post-operatively. Likewise, the mean S100B serum level significantly increased in group 2 after surgery (p < 0.0001). In this group patients undergoing acute surgery showed a mean S100B serum level of 0.23 ± 0.14 μg L(-1) and 1.11 ± 0.73 μg L(-1) pre- and post-operatively.

CONCLUSION

This study demonstrates significant alterations of the biomarker S100B serum levels in patients undergoing surgery. Higher S100B serum levels were found within 24 hours and might be related to the acute fracture. The NSE serum levels were unchanged and this biomarker may offer the probability to serve as a future outcome predictor in studies with patients with traumatic brain injury and additional extracerebral injuries.

Fibrinogen but not factor XIII deficiency is associated with bleeding after craniotomy

BACKGROUND

Postoperative haemorrhage in neurosurgery is associated with significant morbidity and mortality. There is controversy whether or not factor XIII (FXIII) deficiency leads to bleeding complications after craniotomy. Decreased fibrinogen levels have been associated with an increased incidence of bleeding complications in cardiac and orthopaedic surgery. The aim of this study was to assess perioperative fibrinogen and FXIII levels in patients undergoing elective intracranial surgery with and without severe bleeding events.

METHODS

Perioperative FXIII and fibrinogen levels were prospectively assessed in 290 patients undergoing elective craniotomy. Patients were divided into two groups according to the presence or absence of severe bleeding requiring surgical revision. Coagulation test results of these groups were compared using Student's t-test.

RESULTS

The incidence of postoperative severe bleeding was 2.4%. No differences in FXIII levels were observed, but postoperative fibrinogen levels were significantly lower in patients suffering from postoperative haematoma compared with those without postoperative intracranial bleeding complications [237 mg dl(-1) (standard deviation, SD 86) vs 170 mg dl(-1) (SD 35), P=0.03]. The odds ratio for postoperative haematoma in patients with a postoperative fibrinogen level below 200 mg dl(-1) was 10.02 (confidence interval: 1.19-84.40, P=0.03).

CONCLUSIONS

This study emphasizes the role of fibrinogen as potentially modifiable risk factor for perioperative bleeding in intracranial surgery. Future randomized controlled trials will be essential to identify patients who might benefit from fibrinogen substitution during neurosurgical procedures.

[Biodegradable cage. Osteointegration in spondylodesis of the sheep cervical spine]

Bioabsorbable implants are commonplace in knee and shoulder surgery. Bioabsorbable poly(l-lactide-co-D,L-lactide) (PLDLLA) cage devices have potential benefits over autologous tricortical iliac crest bone graft and metallic cages for cervical spine interbody fusion. The purpose of this study was to compare interbody fusion of an autologous tricortical iliac crest bone graft with that of a bioabsorbable cage using a sheep cervical spine interbody fusion model. This study was designed to determine differences in (1) the ability to preserve postoperative distraction, (2) biomechanical stability, and (3) histological characteristics of intervertebral bone matrix formation. Sixteen full-grown Merino sheep underwent C3/4 discectomy and fusion. After 12 weeks, there was no significant difference between the results with the bioabsorbable PLDLLA cages and tricortical bone grafts. The cage also did not show advanced interbody fusion but did, however, show large osteolysis, which allows skepticism regarding the value of this bioabsorbable implant.